The Effects of Allopurinol on Levels of Cardiac Troponin Following Non-ST Elevation Myocardial Infarction: A Pilot Randomized Clinical Trial
Background: Given the potential anti-ischemic effects of allopurinol, we aimed to assess whether allopurinol administration may reduce myocardial injury following non-ST elevation myocardial infarction (NSTEMI). Methods: A randomized clinical trial (RCT) was conducted on 100 individuals with NSTEMI....
Guardado en:
Autores principales: | Sajad Khiali, Parvin Sarbakhsh, Sina Mashayekhi, Elham Mohamadrezapour, Samaneh Dousti, Taher Entezari-Maleki |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Tabriz University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1303c2d95f864733a97c57e1b2573ddc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development of Liposome-Based Immunoassay for the Detection of Cardiac Troponin I
por: Remya Radha, et al.
Publicado: (2021) -
A Novel Use of Allopurinol as A Quorum-Sensing Inhibitor in <i>Pseudomonas aeruginosa</i>
por: Ahmed Al Saqr, et al.
Publicado: (2021) -
ASSOCIATION OF THROMBOLYSIS IN MYOCARDIAL INFARCTION (TIMI) RISK SCORE WITH EXTENT OF CORONARY ARTERY DISEASE IN PATIENTS WITH UNSTABLE ANGINA AND NSTEMI
por: Saleha Abbas, et al.
Publicado: (2020) -
Xanthine Oxidase Inhibitor Allopurinol Prevents Oxidative Stress‐Mediated Atrial Remodeling in Alloxan‐Induced Diabetes Mellitus Rabbits
por: Yajuan Yang, et al.
Publicado: (2018) -
COMPARISON OF INTRACORONARY VERAPAMIL VS ADENOSINE FOR RESTORATION OF CORONARY BLOOD FLOW POST PERCUTANEOUS CORONARY INTERVENTION (PCI) IN PATIENTS WITH NO-REFLOW
por: Mohsin Saif, et al.
Publicado: (2020)